Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability

NCT05853198 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT05853198
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05853198 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA as Surgical Biomarker in Patients With PancrEatic Adenocarcinoma for Statement of Resectability
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Not applicable
Overall status
Unknown status
Start date
December 29, 2022
Completion date
May 31, 2026
Enrollment
165 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pdac - pancreatic ductal adenocarcinoma